CHEMISTRY
Products
AboutSafetyClientsContacts

Technical Guide · Tech Serve Solutions

Caffeine Anhydrous: A Complete Technical Guide

Caffeine Anhydrous (CAS 58-08-2) is the dehydrated, crystalline form of caffeine — chemically identical to the caffeine in coffee, but supplied as a pure 99%+ powder for pharmaceutical, nutraceutical, beverage, and cosmetic manufacturing. This guide covers its chemistry, production, applications, regulations across the US and EU, and how to source it in bulk.

Published 19 May 2026 · Reviewed by Tech Serve Solutions · CAS 58-08-2 · Mol. formula C₈H₁₀N₄O₂


What is caffeine anhydrous?

Caffeine anhydrous is pure caffeine with all water removed. The chemical name is 1,3,7-trimethylxanthine (formula C₈H₁₀N₄O₂, molecular weight 194.19 g/mol, CAS 58-08-2). The word "anhydrous" means "without water" — distinguishing it from caffeine monohydrate, which carries one molecule of water per molecule of caffeine.

At room temperature, caffeine anhydrous is a white, odourless, bitter-tasting crystalline powder. It melts at 234–239 °C and is moderately soluble in water, freely soluble in chloroform, and sparingly soluble in ethanol.

Commercially, caffeine anhydrous is the form used in nearly every tablet, capsule, energy drink, pre-workout powder, and pharmaceutical formulation that contains caffeine. The crystalline anhydrous form has precise weight, stable dosing, and excellent shelf life — qualities the wet or hydrated forms cannot match.


Caffeine anhydrous vs. regular caffeine (and vs. caffeine monohydrate)

At the molecular level, there is no difference. "Caffeine" — whether extracted from coffee, tea, kola, or guarana — is the same compound: 1,3,7-trimethylxanthine. What differs is the physical state and the water content.

FormWater contentTypical use
Caffeine anhydrous~0% (≤0.5%)Tablets, capsules, pre-workout powders, energy drinks
Caffeine monohydrate~8.5% (one mole H₂O)Older pharma formulations, some regional pharmacopoeias
Caffeine in coffeeaqueous solutionBeverage
Caffeine citratesalt complexPharmaceutical (neonatal apnoea treatment)

The choice between anhydrous and monohydrate is mostly historical and regional. Anhydrous offers slightly tighter dose control (no water mass to account for), so formulators of high-precision products prefer it.


How is caffeine anhydrous made?

Two principal routes are used commercially:

1. Extraction (natural origin)

Caffeine is recovered from coffee or tea waste streams — primarily green coffee bean dust from decaffeination plants. Supercritical CO₂ or solvent (typically dichloromethane or ethyl acetate) extracts the caffeine, which is then recrystallised and dried to remove all water, yielding caffeine anhydrous.

2. Synthesis (synthetic origin)

The Traube purine synthesis condenses dimethylurea with malonic acid to build the xanthine ring system, which is then methylated to yield 1,3,7-trimethylxanthine. Most globally traded caffeine anhydrous is synthetic — the route is cheaper, more scalable, and gives a more consistent impurity profile.

Both routes converge on the same molecule. Pharmacopoeia grades require recrystallisation, assay confirmation (≥98.5%), and heavy-metals testing regardless of origin. Some markets — particularly EU natural-product consumers — prefer extracted caffeine and pay a premium, but for pharmaceutical, beverage, and supplement use the synthetic and naturally-extracted forms are interchangeable.


Molecular structure and physical properties

CAS number58-08-2
Chemical name1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
SynonymsCaffeine; Theine; Methyltheobromine; 1,3,7-Trimethylxanthine; Coffeine
Molecular formulaC₈H₁₀N₄O₂
Molecular weight194.19 g/mol
AppearanceWhite, odourless, bitter, crystalline powder
Melting point234–239 °C
Solubility (water)~22 g/L at 25 °C
pH (1% aqueous)5.5 – 6.5
Heavy metals≤ 10 ppm
HSN / HS code2939 30 00

Half-life and metabolism

In healthy adult humans the biological half-life of caffeine is approximately 5 hours, regardless of source. Caffeine is metabolised primarily in the liver by the cytochrome P450 enzyme CYP1A2 to paraxanthine (~84%), theobromine (~12%), and theophylline (~4%) — three further bioactive compounds.

Half-life is shortened in smokers (down to ~3 hours), and extended in pregnant women (up to 10 hours in the third trimester), in patients on oral contraceptives, and in neonates (where caffeine clearance is very slow — hence the use of caffeine citrate to treat apnoea of prematurity).


Industrial applications of caffeine anhydrous

Pharmaceutical formulations

Caffeine anhydrous is a registered pharmaceutical active in numerous monographs. It is used as a respiratory stimulant (notably as caffeine citrate for neonatal apnoea), as an analgesic adjuvant (potentiating paracetamol and aspirin in over-the-counter headache and migraine preparations), and as a stimulant in cold and flu preparations.

Nutraceuticals and sports supplements

Pre-workout powders and capsules typically contain 100–300 mg of caffeine anhydrous per serving — the precise dose-ability of the anhydrous form makes it the standard ingredient. It is paired with L-theanine, beta-alanine, creatine, and other ergogenic aids in performance formulations.

Functional beverages and energy drinks

Energy drinks, energy shots, energy gels, energy gums, and functional sodas all use caffeine anhydrous as their primary active. FCC-grade (food-grade) caffeine anhydrous is the standard specification.

Cosmetics

Caffeine anhydrous appears in eye creams (claimed to reduce puffiness via vasoconstriction), anti-cellulite creams, shampoos targeting hair loss, and tanning products. Cosmetic grade caffeine anhydrous is typically a subset of the pharmaceutical grades.

Industrial and analytical reagent

Analytical-grade caffeine anhydrous is used as a reference standard in HPLC and UV-spectroscopic methods, and as a model alkaloid in undergraduate organic chemistry laboratories.


Caffeine anhydrous dosage

The US Food and Drug Administration considers up to 400 mg of caffeine per day safe for most healthy adults — equivalent to roughly four to five cups of brewed coffee.

Is 200 mg a lot?

No. 200 mg is a moderate single dose — common in pre-workout supplements and headache medications. Roughly two cups of coffee. Most healthy adults tolerate it well.

Is 300 mg a lot?

Higher but within safe daily limits. 300 mg in a single serving is found in some pre-workout supplements aimed at trained athletes. Caffeine-sensitive individuals, pregnant women, and people with cardiovascular conditions should consult a clinician before consuming this in one dose.

FDA limits and bulk caffeine

In 2018 the FDA prohibited the sale of bulk pure caffeine powder direct to consumers in the United States, after several deaths from accidental overdose. The restriction does not apply to manufacturers using caffeine anhydrous as an ingredient in finished pharmaceutical or supplement products — bulk B2B supply to registered manufacturers remains legal.


Side effects and contraindications

Common side effects at typical doses (100–300 mg) include increased alertness, mild diuresis, transient elevation of heart rate and blood pressure, and reduced perception of fatigue. At higher doses (≥ 600 mg) users may experience jitteriness, anxiety, palpitations, insomnia, gastrointestinal upset, and tremor. Acute toxicity is rare below 1 g but becomes serious above 5 g (fatal cases have been documented at 5–10 g of ingested pure caffeine anhydrous).

Caffeine and cortisol

Acute caffeine intake transiently elevates cortisol — particularly in non-habitual consumers. Habitual users develop tolerance to this effect within days to weeks. Cortisol response is more pronounced when caffeine is taken at rest than during exercise.

Who should limit caffeine

  • Pregnant or breastfeeding women (limit to 200 mg/day per ACOG guidance)
  • People with cardiac arrhythmias or uncontrolled hypertension
  • People with anxiety disorders or insomnia
  • Children and adolescents (no established safe daily intake)
  • People on theophylline, ciprofloxacin, fluvoxamine, or MAOI medications

Regulations and compliance

United States — USP grade and FDA

Caffeine anhydrous USP is the dominant grade in the US pharma and supplement market. It is GRAS (Generally Recognised As Safe) for use in cola-type beverages up to 0.02% by weight. For dietary supplements, the ingredient is permitted under DSHEA. Manufacturers must source from FDA-registered facilities and maintain COA records per lot.

European Union — EP grade, REACH, EFSA

Caffeine anhydrous in EU markets must comply with the European Pharmacopoeia (Ph. Eur. / EP). EFSA has confirmed safety for adult daily intakes up to 400 mg per day and 200 mg per single occasion. Supply into the EU requires REACH registration; chemical labelling must follow CLP (Classification, Labelling and Packaging) regulation requirements.

India — IP grade

Caffeine anhydrous IP is supplied for the Indian pharmaceutical market and for export to markets accepting Indian Pharmacopoeia compliance.

Food applications — FCC grade

The Food Chemicals Codex (FCC) specifies caffeine anhydrous purity, heavy metals, and microbial limits for food and beverage use. FCC and food-grade specifications are required for energy-drink, functional-beverage, and fortified-food manufacturers.


Sourcing caffeine anhydrous in bulk

What to ask a supplier

  • What grades do you supply? (USP / BP / EP / IP / FCC / food / nutraceutical)
  • Is the material synthetic or naturally extracted?
  • What is the typical lead time and MOQ?
  • Can you provide a COA for the most recent batch?
  • Are samples available, and at what cost?
  • What is the packaging — 25 kg fibre drum, 500 kg big bag, sample bag?
  • Do you have REACH registration for EU supply?
  • Is the manufacturing facility cGMP-compliant?
  • Do you ship hazmat? (Caffeine anhydrous itself is not hazmat, but bulk export procedures vary)
  • What is your pricing structure — fixed list or quote-on-request?

How Tech Serve Solutions supplies caffeine anhydrous

TSS supplies caffeine anhydrous in USP, BP, EP, IP, FCC, food, and nutraceutical grades, with assay ≥98.5% on anhydrous basis. Standard packaging is the 25 kg fibre drum. Sample quantities are available from 100 g (foil bag). For EU pharma customers, 500 kg big-bag packaging is supplied on request. Lead time is 7–10 working days for in-stock material; custom-spec orders ship in 3–4 weeks. We supply 30+ countries with full COA, MSDS, REACH documentation for EU shipments, and regulatory packets per buyer market.

Need a quote or sample?

Pricing and lead times for caffeine anhydrous depend on grade, packaging, and destination market.

View product details & request quote →

References & further reading

This guide is published by Tech Serve Solutions, a chemical supplier since 1989. It is intended for B2B procurement, technical, and regulatory audiences — not as medical advice for end consumers. For dosing or clinical questions consult a qualified healthcare professional.